Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 430, 819 (19 August 2004) | doi:10.1038/430819b; Published online 18 August 2004
Firm sets sights on gene silencing to protect vision
Erika Check
A much-hyped technology known as RNA interference (RNAi) has moved a step closer to the clinic.Biotechnology firm Acuity Pharmaceuticals of Philadelphia, Pennsylvania, asked for permission on 10 August to use the technique to treat a common cause of blindness.
To read this story in full you will need to login or make a payment (see right).